Results
20,303 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 20 | 0xa855…3c74Wallet |  SLViShares Silver TrustBurn / redemption | SELL | $52K 1,094 sh | Nov 4, 22:16 UTC traded Nov 4, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 20 | 0xa855…3c74Wallet | SLViShares Silver Trust Burn / redemption | SELL | $52K 1,094 sh | Nov 4, 22:16 UTC traded Nov 4, 2026 | |
0xa855…3c74Wallet |
 USOUnited States Oil Fund, LPBurn / redemption |
| SELL |
| $38K 261 sh |
| Nov 4, 22:15 UTC traded Nov 4, 2026 |
| 20 | 0xa855…3c74Wallet | USOUnited States Oil Fund, LP Burn / redemption | SELL | $75K 519 sh | Nov 4, 22:15 UTC traded Nov 4, 2026 |
| 53 | Sing George LDirector |  REGNREGENERON PHARMACEUTICALS, INC.Open-market sale | SELL | $6.83M 7,073 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 49 | Garceau Mary LSVP - CLO and Secretary |  SHWSHERWIN WILLIAMS COOpen-market sale | SELL | $1.36M 3,891 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 49 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $4.18M 4,338 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 49 | Larosa Joseph JEVP General Counsel and Secret | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $3.80M 3,939 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 49 | Way T LawrenceDirector |  CUBICustomers Bancorp, Inc.Open-market sale | SELL | $4.09M 48.8K sh | Nov 4, 2026 traded Oct 30, 2026 |
| 49 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $1.47M 1,522 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 49 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $2.58M 2,670 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 49 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $2.43M 2,522 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 47 | Skeete Bernard MChief Accounting Officer |  VLTOVeralto CorpOpen-market sale | SELL | $170K 1,514 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 45 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $1.01M 1,040 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 45 | Pope Daniel MDirector |  TYLTYLER TECHNOLOGIES INCOpen-market sale | SELL | $277K 680 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 45 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $1.18M 1,224 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 44 | Clay CraigSenior Advisor |  DFINDonnelley Financial Solutions, Inc.Open-market sale | SELL | $1.45M 21.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 44 | Treff Douglas JDirector |  CROXCrocs, Inc.Open-market sale | SELL | $1.10M 7,185 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 44 | Clay CraigSenior Advisor | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $1.89M 28.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 44 | Clay CraigSenior Advisor | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $1.45M 21.5K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 43 | Bichara GuillermoExec VP & Chief Legal Officer |  LINLINDE PLCOpen-market sale | SELL | $4.85M 9,350 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 42 | Larosa Joseph JEVP General Counsel and Secret | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $509K 527 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 42 | Murphy Robert MadisonDirector |  MUSAMurphy USA Inc.Open-market sale | SELL | $589K 1,000 sh | Nov 4, 2026 traded May 4, 2026 |
| 42 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $519K 540 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 41 | Turner KamiChief Accounting Officer | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $406K 6,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 41 | Turner KamiChief Accounting Officer | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $406K 6,100 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 40 | Olschan Brian SDirector, President and COO |  ACUACME UNITED CORPOpen-market sale | SELL | $982K 14.2K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 39 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $194K 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 39 | Heyer Andrew RDirector |  OSWONESPAWORLD HOLDINGS LtdOpen-market sale | SELL | $183K 7,000 sh | Nov 4, 2026 traded Aug 20, 2026 |
| 38 | Chybowski Joseph M.PRESIDENT & CFO |  BWBBridgewater Bancshares IncOpen-market sale | SELL | $197K 9,651 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 38 | Murphy Robert MadisonDirector | MUSAMurphy USA Inc. Open-market sale | SELL | $624K 1,000 sh | Nov 4, 2026 traded Jul 29, 2026 |
| 38 | Lindquist Scott REVP & CFO |  CNACNA FINANCIAL CORPOpen-market sale | SELL | $1.12M 23.6K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 37 | Clay CraigSenior Advisor | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $309K 4,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 37 | Treff Douglas JDirector | CROXCrocs, Inc. Open-market sale | SELL | $515K 3,416 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 37 | Murphy Susan HDirector | ACUACME UNITED CORP Open-market sale | SELL | $194K 2,890 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 37 | Treff Douglas JDirector | CROXCrocs, Inc. Open-market sale | SELL | $471K 3,101 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 37 | Clay CraigSenior Advisor | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $986K 14.5K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 36 | Bradley Mark ChristopherChief Development Officer |  ALMSALUMIS INC.Open-market sale | SELL | $4,062 623 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 36 | Schroer John R.Chief Financial Officer | ALMSALUMIS INC. Open-market sale | SELL | $5,177 794 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 36 | Murray CiaranDirector |  ICLRICON PLCOpen-market sale | SELL | $710K 3,452 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 36 | Hardiman Roy C.Chief Business & Strategy Ofcr | ALMSALUMIS INC. Open-market sale | SELL | $4,251 652 sh | Nov 4, 2026 traded Nov 2, 2026 |